Development of the Participation Scale for Patients with Congestive Heart Failure (PS-CHF).
Development of the Participation Scale for Patients with Congestive Heart Failure (PS-CHF).
复制标题
充血性心力衰竭 (PS-CHF) 患者参与量表的制定。
DOI：
10.1097/phm.0b013e31824ad653
复制
发表时间：
2012
影响因子：
3
通讯作者：
Toyoaki Murohara.
中科院分区：
文献类型：
--
作者：
Makoto Suzuki;Sumio Yamada;Yuko Shimizu;Yuji Kono;Akihiro Hirashiki;Hideo Izawa;Toyoaki Murohara.
我们报告了充血性心力衰竭（CHF）患者参与测量的发展-CHF患者参与量表（PS-CHF）-及其单维性、可靠性和效度的确定。设计本研究包括两轮数据收集：第一轮入组了62例患者，目的是减少项目，130名CHF患者和96名健康对照者参加了第二轮问卷validation.ResultsThe PS CHF被组织成五个项目，旨在询问参与的限制。PS-CHF评分范围为5分（最低参与水平）至20分（最高参与水平）。在Rasch分析中，项目校准范围从最困难项目的+ 0.51 logit到最不困难项目的-0.56 logit。不适合者的均方统计值范围为1.20-0.81，适合者的均方统计值范围为1.34-0.72。两次连续给予PS-CHF（间隔2周）的评分之间的组内相关系数为0.94。CHF患者的总PS-CHF评分显着低于健康controls.ConclusionsThe PS-CHF的发展，以确定CHF患者的疾病特异性参与措施。PS-CHF可作为CHF患者的具有临床意义的结局指标。
ObjectiveWe report on the development of a participation measure for patients with congestive heart failure (CHF)—the Participation Scale for Patients with CHF (PS-CHF)—and the determination of its unidimensionality, reliability, and validity.DesignThis study included two rounds of data collections: 62 patients enrolled in the first round for the purpose of item reduction, and 130 CHF patients and 96 healthy controls participated in the second round for questionnaire validation.ResultsThe PS-CHF was organized into five items designed to ask about limitations to participation. The PS-CHF score ranges from 5 points (lowest level of participation) to 20 points (highest level of participation). On Rasch analysis, the item calibrations ranged from+ 0.51 logit for the most difficult item to− 0.56 logit for the least difficult item. The range of mean square statistics values was 1.20–0.81 for infit and 1.34–0.72 for outfit. The intraclass correlation coefficient between scores from two successive administrations of the PS-CHF, separated by 2 wks, was 0.94. The total PS-CHF score in CHF patients was significantly lower than in healthy controls.ConclusionsThe PS-CHF was developed to determine a disease-specific participation measure for patients with CHF. The PS-CHF may serve as a clinically meaningful outcome measure for CHF patients.